IDEAS home Printed from https://ideas.repec.org/a/spr/wirtsc/v101y2021i2d10.1007_s10273-021-2852-2.html
   My bibliography  Save this article

Ist eine Impfpflicht gegen das Coronavirus nötig?
[Is Mandatory Vaccination Against the Coronavirus Necessary?]

Author

Listed:
  • Thomas Wein

    (Leuphana Universität Lüneburg)

Abstract

Zusammenfassung An die Zulassung der SARS-CoV-2-Impfstoffe knüpft sich die Hoffnung, die Pandemie schnellstmöglich überwinden zu können. Befragungen zeigen jedoch eine begrenzte Impfbereitschaft, die für eine Herdenimmunität eventuell nicht ausreicht. Im vorliegenden Beitrag wird spieltheoretisch untersucht, wie die einzelne Impfentscheidung im Hinblick auf das Impfverhalten der anderen ausfällt. Es zeigt sich, dass sich impfen zu lassen keine dominate Strategie ist. Die Wahrscheinlichkeit sich impfen zu lassen, nimmt jedoch mit den langfristigen Kosten der Pandemie zu. Demnach könnte die Impfbereitschaft erhöht werden, wenn die Politik stärker über die Folgekosten aufklären würde. Dann könnte eine Impfpflicht vermieden werden.

Suggested Citation

  • Thomas Wein, 2021. "Ist eine Impfpflicht gegen das Coronavirus nötig? [Is Mandatory Vaccination Against the Coronavirus Necessary?]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 101(2), pages 114-120, February.
    • Handle: RePEc:spr:wirtsc:v:101:y:2021:i:2:d:10.1007_s10273-021-2852-2
    DOI: 10.1007/s10273-021-2852-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10273-021-2852-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10273-021-2852-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Sebastian Neumann-Böhme & Nirosha Elsem Varghese & Iryna Sabat & Pedro Pita Barros & Werner Brouwer & Job Exel & Jonas Schreyögg & Tom Stargardt, 2020. "Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(7), pages 977-982, September.
    2. Daniel Graeber & Christoph Schmidt-Petri & Carsten Schröder, 2020. "Covid-19: Mehrheit der Deutschen würde sich freiwillig impfen lassen, die Hälfte ist für eine Impfpflicht," DIW aktuell 54, DIW Berlin, German Institute for Economic Research.
    3. Francis, Peter J., 1997. "Dynamic epidemiology and the market for vaccinations," Journal of Public Economics, Elsevier, vol. 63(3), pages 383-406, February.
    4. Brito, Dagobert L. & Sheshinski, Eytan & Intriligator, Michael D., 1991. "Externalities and compulsary vaccinations," Journal of Public Economics, Elsevier, vol. 45(1), pages 69-90, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Dieter Cassel & Volker Ulrich, 2021. "Corona-Impfstoffe im Überfluss — was dann? [Coronavirus Vaccines in Abundance — What Then?]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 101(4), pages 276-283, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
    2. Proano, Ruben A. & Jacobson, Sheldon H. & Zhang, Wenbo, 2012. "Making combination vaccines more accessible to low-income countries: The antigen bundle pricing problem," Omega, Elsevier, vol. 40(1), pages 53-64, January.
    3. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
    4. Kessing, Sebastian G. & Nuscheler, Robert, 2006. "Monopoly pricing with negative network effects: The case of vaccines," European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
    5. Mark Gersovitz & Jeffrey S. Hammer, 2004. "The Economical Control of Infectious Diseases," Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.
    6. Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
    7. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
    8. Barrett, Scott & Hoel, Michael, 2007. "Optimal disease eradication," Environment and Development Economics, Cambridge University Press, vol. 12(5), pages 627-652, October.
    9. Philipson, Tomas, 2000. "Economic epidemiology and infectious diseases," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799, Elsevier.
    10. Shosh Shahrabani & Amiram Gafni & Uri Ben-Zion, 2008. "Low Flu Shot Rates Puzzle—Some Plausible Behavioral Explanations," The American Economist, Sage Publications, vol. 52(1), pages 66-72, March.
    11. Jelnov, Artyom & Jelnov, Pavel, 2022. "Vaccination policy and trust," Economic Modelling, Elsevier, vol. 108(C).
    12. Zachary S. Brown & Randall A. Kramer, 2018. "Preference Heterogeneity in the Structural Estimation of Efficient Pigovian Incentives for Insecticide Spraying to Reduce Malaria," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 70(1), pages 169-190, May.
    13. Toxvaerd, F. & Rowthorn, R., 2020. "On the Management of Population Immunity," Cambridge Working Papers in Economics 2080, Faculty of Economics, University of Cambridge.
    14. Amarakoon Bandara, 2005. "Emerging health isues in Asia and the Pacific: implications for public health policy," Asia-Pacific Development Journal, United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), vol. 12(2), pages 33-58, December.
    15. Francis, P.J. Peter J., 2004. "Optimal tax/subsidy combinations for the flu season," Journal of Economic Dynamics and Control, Elsevier, vol. 28(10), pages 2037-2054, September.
    16. Corey White, 2021. "Measuring Social and Externality Benefits of Influenza Vaccination," Journal of Human Resources, University of Wisconsin Press, vol. 56(3), pages 749-785.
    17. Konstantinos Gkillas & Christoforos Konstantatos & Costas Siriopoulos, 2021. "Uncertainty Due to Infectious Diseases and Stock–Bond Correlation," Econometrics, MDPI, vol. 9(2), pages 1-18, April.
    18. Terrence August & Tunay I. Tunca, 2006. "Network Software Security and User Incentives," Management Science, INFORMS, vol. 52(11), pages 1703-1720, November.
    19. Troy Tassier & Philip Polgreen & Alberto Segre, 2015. "Vaccination Games with Peer Effects in a Heterogeneous Hospital Worker Population," Administrative Sciences, MDPI, vol. 5(1), pages 1-25, January.
    20. Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(2), pages 121-134, June.

    More about this item

    JEL classification:

    • H12 - Public Economics - - Structure and Scope of Government - - - Crisis Management
    • D62 - Microeconomics - - Welfare Economics - - - Externalities
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:wirtsc:v:101:y:2021:i:2:d:10.1007_s10273-021-2852-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.